Loading...

Moolec Science S.A.

MLECWNASDAQ
Healthcare
Biotechnology
$0.02
$0.001(8.67%)

Moolec Science S.A. (MLECW) Stock Overview

Explore Moolec Science S.A.’s financial performance, market position, analyst ratings, and future outlook.

Meyka AI Score

C+

Score: 59.1/100

Key Financials

Market Cap29M
P/E Ratio-30.09
EPS (TTM)N/A
ROE-1.51%
Fundamental Analysis

AI Price Forecasts

1 Week$0.01
1 Month$0.02
3 Months$0.01
1 Year Target$0.02

MLECW Stock Analysis & Investment Overview

Our comprehensive AI-powered analysis of Moolec Science S.A. (MLECW) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of C+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.

Our forecasting models predict significant price movements, with a 12-month target of $0.02.

Key financial metrics showcase the company's fundamental strength, including a P/E ratio of -30.09 and a market capitalization of 29M. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.

Stats data is not available for MLECWStats details for MLECW are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.
Analyst Recommendations data is not available for MLECWAnalyst Recommendations details for MLECW are currently unavailable. We're actively monitoring for updates and will publish them as soon as they’re released. Please check back again shortly.

Company Profile

Moolec Science SA, a science-based ingredient company, focuses on producing animal proteins in plants through Molecular Farming, a disruptive technology in the alternative protein landscape. The company's product portfolio and pipeline leverage the agronomic efficiency of used target crops, such as soybeans and peas. It operates in the United States, Europe, and South America. The company was founded in 2008 and is based in Luxembourg.

CEO

Henk Hoogenkamp

Employees

52

Headquarters

17 Boulevarrd F.W. Raiffeisen,, Luxembourg

Founded

2023

Frequently Asked Questions

;